Vir-JPM-2025-Conference-Presentation.pdf

1、1January 14,2025J.P.Morgan 2025 J.P.Morgan 2025 Healthcare Conference Healthcare Conference Confidential 2024 Vir Biotechnology,Inc.Legal disclaimer2Forward-Looking StatementsStatements in this presentation that are not statements of historical fact are forward-looking statements.Such forward-lookin

2、g statements include,without limitation,statements regarding:the therapeutic potential of Vir Biotechnologys oncology solid tumor portfolio,preclinical pipeline and PRO-XTENTM masked TCE platform,as well as Vir Biotechnologys strategy,plans and expectations related thereto;the therapeutic potential

3、of Vir Biotechnologys CHD and CHB programs,as well as Vir Biotechnologys strategy,plans and expectations related thereto;the potential of and Vir Biotechnologys expectations for its other pipeline programs;Vir Biotechnologys cash balance and anticipated cash runway;Vir Biotechnologys clinical develo

4、pment plans and expectations for its oncology and hepatitis programs,including protocols for and enrollment into ongoing and planned clinical trials,potential partnering opportunities,and data readouts and presentations,as well as anticipated timelines;the potential benefits,safety and efficacy of V

5、ir Biotechnologys investigational therapies;and any assumptions underlying any of the foregoing.Words such as“aim,”“anticipate,”“believe,”“could,”“expect,”“goal,”“intend,”“may,”“plan,”“potential,”“promising,”“will,”and similar expressions are intended to identify forward-looking statements,though no

6、t all forward-looking statements necessarily contain these identifying words.These forward-looking statements are based on the beliefs of the management of Vir Biotechnology,as well as assumptions made by and information currently available to management.Such statements reflect the current views of